Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-19

FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Amitriptyline hydrochloride from Rising Pharma Holdings, Inc. under an Original Application (generic) for the treatment of major depressive disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amitriptyline hydrochloride (amitriptyline hydrochloride)

Snippet

ORIG AP for AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE)